NCT05873777View on ClinicalTrials.gov

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 9, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
SSTR2FAPPositron-Emission Tomography
Interventions
DIAGNOSTIC_TEST

18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT

Each subject receives a single intravenous injection of 18F-FDG and 68Ga-FAP-LM3, and undergo PET/CT imaging within the specified time. A part of participants will undergo additional 68Ga-FAPI-46 PET/CT for comparison.

Trial Locations (1)

0086-361000

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER